-
2023-509606-30-00
5
2024-07-24
Ulcerative colitis
-
2022-501606-35-01
11
2024-02-21
Platinum-sensitive epithelial ovarian, fallopian tube, or primary
peri
-
2022-501703-27-00
5
2023-07-05
Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
-
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
-
2022-500257-16-00
5
2023-03-17
Diabetic Foot Infections
-
2023-506548-18-00
10
2022-11-10
Dermatitis atopic
-
2023-505766-28-00
10
2022-10-10
Hereditary angioedema
-
2022-501893-21-00
4
2022-05-03
Acute myocardial infarction
-
2023-505749-14-00
5
2022-03-20
c-Met overexpressing EGFR wildtype non-squamous non-small cell lung ca
-
2023-506784-33-00
5
2021-01-19
RET fusion-Positive NSCLC
-
2023-505261-84-00
5
2020-10-06
Primary high risk leiomyosarcoma or liposarcoma of retroperitoneal spa
-
2025-523475-33-00
6
2026-05-18
Primary apnea in preterms newborns
-
2024-516993-31-00
5
2026-05-11
Renal Cell Carcinoma
-
2025-523552-31-00
5
2026-05-07
Systemic Lupus Erythematosus
-
2025-523974-18-00
5
2026-04-30
Obesity
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2025-523224-45-00
10
2026-03-30
Untreated, Unresectable or Metastatic Colorectal Cancer
-
2023-504957-11-00
5
2026-03-24
Metastatic castration resistant prostate cancer
-
2025-521036-11-00
5
2026-03-23
Immune system disseases
-
2025-522232-13-00
4
2026-03-06
Sepsis-associated acute kidney injury (AKI)
-
2025-521035-37-00
5
2026-03-02
Immune system diseases
-
2024-511101-28-00
4
2026-02-24
Episodic Migraine
Chronic Migraine
-
2024-516966-12-00
4
2026-02-13
Alzheimer’s disease